30
views
0
recommends
+1 Recommend
0 collections
    3
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The Effect of Superparamagnetic Iron Oxide Nanoparticle Surface Charge on Antigen Cross-Presentation

      brief-report

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Magnetic nanoparticles (NPs) of superparamagnetic iron oxide (SPIO) have been explored for different kinds of applications in biomedicine, mechanics, and information. Here, we explored the synthetic SPIO NPs as an adjuvant on antigen cross-presentation ability by enhancing the intracellular delivery of antigens into antigen presenting cells (APCs). Particles with different chemical modifications and surface charges were used to study the mechanism of action of antigen delivery. Specifically, two types of magnetic NPs, γFe 2O 3/APTS (3-aminopropyltrimethoxysilane) NPs and γFe 2O 3/DMSA (meso-2, 3-Dimercaptosuccinic acid) NPs, with the same crystal structure, magnetic properties, and size distribution were prepared. Then, the promotion of T-cell activation via dendritic cells (DCs) was compared among different charged antigen coated NPs. Moreover, the activation of the autophagy, cytosolic delivery of the antigens, and antigen degradation mediated by the proteasome and lysosome were measured. Our results indicated that positive charged γFe 2O 3/APTS NPs, but not negative charged γFe 2O 3/DMSA NPs, enhanced the cross-presentation ability of DCs. Increased cross-presentation ability induced by γFe 2O 3/APTS NPs was associated with increased cytosolic antigen delivery. On the contrary, γFe 2O 3/DMSA NPs was associated with rapid autophagy. Overall, our results suggest that antigen delivered in cytoplasm induced by positive charged particles is beneficial for antigen cross-presentation and T-cell activation. NPs modified with different chemistries exhibit diverse biological properties and differ greatly in their adjuvant potentials. Thus, it should be carefully considered many different effects of NPs to design effective and safe adjuvants.

          Related collections

          Most cited references21

          • Record: found
          • Abstract: found
          • Article: not found

          Alpha-alumina nanoparticles induce efficient autophagy-dependent cross-presentation and potent antitumour response

          Therapeutic cancer vaccination is an attractive immune therapy strategy to actively induce T cells that specifically recognize and kill tumour cells in cancer patients. However, it remains difficult to generate a large number antigen-specific T cells using conventional vaccine carrier systems 1,2 . Here we show that α-Al2O3 nanoparticles can act as an antigen carrier to reduce the amount of antigen required by dendritic cells to activate T cells in vitro and in vivo. We found that α- Al2O3 nanoparticles delivered antigens to autophagosomes in dendritic cells (DCs), which then presented the antigens to T cells through autophagy – the normal degradation process of cell components in cells. Immunization of mice with α-Al2O3 nanoparticles that are conjugated to either a model tumour antigen or autophagosomes derived from tumour cells resulted in tumour regression. These results suggest that α-Al2O3 nanoparticles may be a promising adjuvant in the development of therapeutic cancer vaccines.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Intracellular mechanisms of antigen cross presentation in dendritic cells.

            The induction of most CD8+ T cell responses by dendritic cells (DCs) requires the presentation of peptides from internalized antigen by class I MHC molecules. Increasing number of reports have shown that cross presentation is involved in transplant rejection, in immune responses to viral infections, in certain autoimmune diseases and cancer. The precise role of cross presentation in the initiation of immune responses in vivo, however, remains a matter of debate. This ongoing controversy is, at least in part, due to a lack of understanding of the molecular machinery that determine cross presentation pathways in terms of cell biology. The present review aims to summarize recent insights and advances that help enlighten the intracellular steps of antigen cross presentation in DCs. Copyright 2010. Published by Elsevier Ltd.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Biomimetic protein nanoparticles facilitate enhanced dendritic cell activation and cross-presentation.

              Many current cancer vaccine strategies suffer from the inability to mount a CD8 T cell response that is strong enough to overcome the low immunogenicity of tumors. Viruses naturally possess the sizes, geometries, and physical properties for which the immune system has evolved to recognize, and mimicking those properties with nanoparticles can produce robust platforms for vaccine design. Using the nonviral E2 core of pyruvate dehydrogenase, we have engineered a viral-mimicking vaccine platform capable of encapsulating dendritic cell (DC)-activating CpG molecules in an acid-releasable manner and displaying MHC I-restricted SIINFEKL peptide epitopes. Encapsulated CpG activated bone marrow-derived DCs at a 25-fold lower concentration in vitro when delivered with the E2 nanoparticle than with unbound CpG alone. Combining CpG and SIINFEKL within a single multifunctional particle induced ∼3-fold greater SIINFEKL display on MHC I by DCs over unbound peptide. Importantly, combining CpG and SIINFEKL to the E2 nanoparticle for simultaneous temporal and spatial delivery to DCs showed increased and prolonged CD8 T cell activation, relative to free peptide or peptide-bound E2. By codelivering peptide epitopes and CpG activator in a particle of optimal DC-uptake size, we demonstrate the ability of a noninfectious protein nanoparticle to mimic viral properties and facilitate enhanced DC activation and cross-presentation.
                Bookmark

                Author and article information

                Contributors
                yongbinmou@qq.com
                xingyun201410@163.com
                rhy803@gmail.com
                28328118@qq.com
                13851704689@163.com
                guangjie1113@gmail.com
                skqkjk@163.com
                +86 25 83620101 , qghu@nju.edu.cn
                +001 503 215 6531 , hhu@providence.org , hong-ming.hu@providence.org
                Journal
                Nanoscale Res Lett
                Nanoscale Res Lett
                Nanoscale Research Letters
                Springer US (New York )
                1931-7573
                1556-276X
                19 January 2017
                19 January 2017
                2017
                : 12
                : 52
                Affiliations
                [1 ]ISNI 0000 0001 2314 964X, GRID grid.41156.37, Nanjing Stomatological Hospital, , Medical School of Nanjing University, ; 30#, Zhongyang Road, Nanjing, 210008 People’s Republic of China
                [2 ]Laboratory of Cancer Immunobiology, Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center, Portland, OR USA
                [3 ]ISNI 0000 0000 9776 7793, GRID grid.254147.1, Minigene Pharmacy Laboratory, School of Life Science and Technology, , China Pharmaceutical University, ; Nanjing, People’s Republic of China
                [4 ]ISNI 0000 0004 1761 0489, GRID grid.263826.b, Medical School, , Southeast University, ; Nanjing, People’s Republic of China
                [5 ]ISNI 0000 0004 1761 0489, GRID grid.263826.b, State Key Laboratory of Molecule and Bimolecular Electronics, Jiangsu Provincial Laboratory for Biomaterials and Devices, , Southeast University, ; Nanjing, People’s Republic of China
                [6 ]Cancer Research, Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center, 4805 NE Glisan Street, Portland, OR 97213 USA
                Author information
                http://orcid.org/0000-0003-3904-0563
                Article
                1828
                10.1186/s11671-017-1828-z
                5247387
                28102523
                9c8d9010-b160-4194-b316-f2e9e6cf1cd1
                © The Author(s). 2017

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

                History
                : 4 September 2016
                : 31 December 2016
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/100000002, National Institutes of Health;
                Award ID: U43CA165048
                Award Recipient :
                Funded by: National Natural Sciences Foundation of China
                Award ID: 81371680
                Award ID: 81571800
                Award Recipient :
                Categories
                Nano Express
                Custom metadata
                © The Author(s) 2017

                Nanomaterials
                superparamagnetic iron oxide,dendritic cells,adjuvant,antigen cross-presentation
                Nanomaterials
                superparamagnetic iron oxide, dendritic cells, adjuvant, antigen cross-presentation

                Comments

                Comment on this article